Correlation Between NVIDIA CDR and NervGen Pharma

Can any of the company-specific risk be diversified away by investing in both NVIDIA CDR and NervGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NVIDIA CDR and NervGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NVIDIA CDR and NervGen Pharma Corp, you can compare the effects of market volatilities on NVIDIA CDR and NervGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NVIDIA CDR with a short position of NervGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of NVIDIA CDR and NervGen Pharma.

Diversification Opportunities for NVIDIA CDR and NervGen Pharma

-0.37

Correlation Coefficient

NVIDIA CDR  NervGen Pharma

Very good diversification

The 3 months correlation between NVIDIA and NervGen is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding NVIDIA CDR and NervGen Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NervGen Pharma Corp and NVIDIA CDR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NVIDIA CDR are associated (or correlated) with NervGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NervGen Pharma Corp has no effect on the direction of NVIDIA CDR i.e., NVIDIA CDR and NervGen Pharma go up and down completely randomly.

Pair Corralation between NVIDIA CDR and NervGen Pharma

Assuming the 90 days trading horizon NVIDIA CDR is expected to generate 0.52 times more return on investment than NervGen Pharma. However, NVIDIA CDR is 1.92 times less risky than NervGen Pharma. It trades about 0.18 of its potential returns per unit of risk. NervGen Pharma Corp is currently generating about 0.04 per unit of risk. If you would invest  2,498  in NVIDIA CDR on September 4, 2024 and sell it today you would earn a total of  743.00  from holding NVIDIA CDR or generate 29.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

NVIDIA CDR  vs.  NervGen Pharma Corp

NVIDIA CDR

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in NVIDIA CDR are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating technical and fundamental indicators, NVIDIA CDR exhibited solid returns over the last few months and may actually be approaching a breakup point.

NervGen Pharma Corp

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in NervGen Pharma Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, NervGen Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with NVIDIA CDR and NervGen Pharma

The main advantage of trading using opposite NVIDIA CDR and NervGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NVIDIA CDR position performs unexpectedly, NervGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NervGen Pharma will offset losses from the drop in NervGen Pharma's long position.

The idea behind NVIDIA CDR and NervGen Pharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.